Evaluating the hair regenerative potential of plant-based hair serum formulation: a comparative study
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20243799Keywords:
OZiva, Redensyl, Lindera, Hair, Serum, ScalpAbstract
Background: Hair loss, a multifactorial condition influenced by factors such as aging, hormonal imbalances, and genetics, has traditionally been treated with synthetic products like minoxidil and finasteride. However, these treatments often come with significant side effects, highlighting the need for safer and more effective alternatives. This study investigates the efficacy and safety of OZiva+ advanced hair growth serum, a formulation containing 3% Redensyl® and 1% Lindera root extract, as a potential treatment for hair loss.
Methods: The serum's hair growth-promoting effects were evaluated using the ex vivo Philpott test, involving hair plucks from androgenetic alopecia patients, and its safety was assessed through a clinical patch test on human volunteers.
Results: The results demonstrated a significant increase in hair follicle length with the OZiva+ advanced hair growth serum, comparable to 1% minoxidil. Additionally, the serum showed no irritation during the patch study, indicating its safety for use.
Conclusions: The findings suggest that OZiva+ advanced hair growth serum is a promising alternative to traditional hair loss treatments, offering comparable efficacy with fewer side effects. This natural formulation, supported by the synergistic action of Redensyl® and Lindera root extract, holds potential for further development as a safer, more effective solution for hair regrowth and overall hair health.
Metrics
References
Trüeb RM, Rezende HD, Dias MF. A comment on the science of hair aging. Int J Trichol. 2018;10(6):245-54. DOI: https://doi.org/10.4103/ijt.ijt_56_18
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drug Dermatol. 2018;17(4):457.
Jacobs D, Buttigieg CF. Minoxidil Experience In Australia 1974‐1980. Med J Aust. 1981;1(9):477-8. DOI: https://doi.org/10.5694/j.1326-5377.1981.tb135742.x
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-46. DOI: https://doi.org/10.1016/j.jaad.2020.06.1009
Vañó-Galván S, Camacho F. New treatments for hair loss. Actas Dermo-Sifiliográficas. 2017;108(3):221-8. DOI: https://doi.org/10.1016/j.adengl.2017.02.016
Merja A, Patel N, Patel M, Patnaik S, Ahmed A, Maulekhi S. Safety and efficacy of REGENDIL™ infused hair growth promoting product in adult human subject having hair fall complaints (alopecia). J Cosmet Dermatol. 2024;23(3):938-48. DOI: https://doi.org/10.1111/jocd.16084
Filaire E, Dreux A, Boutot C, Ranouille E, Berthon JY. Characteristics of healthy and androgenetic alopecia scalp microbiome: Effect of Lindera strychnifolia roots extract as a natural solution for its modulation. Int J Cosmet Sci. 2020;42(6):615-21. DOI: https://doi.org/10.1111/ics.12657
Karaca N, Akpolat ND. A comparative study between topical 5% minoxidil and topical “redensyl, capixyl, and procapil” combination in men with androgenetic alopecia. J Cosmo Trichol. 2019;5:140.
Katoulis AC, Liakou AI, Koumaki D, Vakirlis E, Tsantes AG, Mortaki D, et al. A randomized, single-blinded, vehicle-controlled study of a topical active blend in the treatment of androgenetic alopecia. Dermatol Ther. 2020;33(4):e13734. DOI: https://doi.org/10.1111/dth.13734
Shapiro J, Price VH. Hair regrowth: therapeutic agents. Dermatol Clin. 1998;16(2):341-56. DOI: https://doi.org/10.1016/S0733-8635(05)70017-6
Philpott MP, Sanders D, Westgate GE, Kealey T. Human hair growth in vitro: a model for the study of hair follicle biology. J Dermatol Sci. 1994;7:S55-72. DOI: https://doi.org/10.1016/0923-1811(94)90036-1
Kwon OS, Han JH, Yoo HG, Chung JH, Cho KH, Eun HC, et al. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine. 2007;14(7-8):551-5. DOI: https://doi.org/10.1016/j.phymed.2006.09.009
Lee YH, Choi HJ, Kim JY, Kim JE, Lee JH, Cho SH, et al. Ginsenoside Rg4 enhances the inductive effects of human dermal papilla spheres on hair growth via the AKT/GSK-3β/β-catenin signalling pathway. J Microbiol Biotechnol. 2021;31(7):933. DOI: https://doi.org/10.4014/jmb.2101.01032
Bai T, Liu F, Zou F, Zhao G, Jiang Y, Liu L, et al. Epidermal growth factor induces proliferation of hair follicle-derived mesenchymal stem cells through epidermal growth factor receptor-mediated activation of ERK and AKT signaling pathways associated with upregulation of cyclin D1 and downregulation of p16. Stem Cell Dev. 2017;26(2):113-22. DOI: https://doi.org/10.1089/scd.2016.0234
Zhao Q, Zheng Y, Zhao D, Zhao L, Geng L, Ma S, et al. Single-cell profiling reveals a potent role of quercetin in promoting hair regeneration. Protein Cell. 2023;14(6):398-415. DOI: https://doi.org/10.1093/procel/pwac062
Park SM, He YC, Gong C, Gao W, Bae YS, Si C, et al. Effects of taxifolin from enzymatic hydrolysis of Rhododendron mucrotulatum on hair growth promotion. Front Bioengineer Biotechnol. 2022;10:995238. DOI: https://doi.org/10.3389/fbioe.2022.995238
Downloads
Published
How to Cite
Issue
Section
